L. Tenthani, A. Haas, and H. Tweya, Ministry of Health in Malawi and IeDEA Southern Africa Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi, AIDS, vol.356, pp.589-9824468999, 2014.

E. Abrams, N. Langwenya, and A. Gachuhi, Impact of Option B+ on ART uptake and retention in Swaziland: a stepped-wedge trial. Abstract 34, Conference on retroviruses and opportunistic infections, pp.22-25, 2016.

O. Manigart, M. Crepin, and V. Leroy, Diminution de la Transmission Mere-Enfant Study Group. Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission, J Infect Dis, vol.356, pp.1422-810, 2004.

P. De-perre, P. Rubbo, and J. Viljoen, HIV-1 reservoirs in breast milk and translational challenges to elimination of breast-feeding transmission of HIV-1, Sci Transl Med, vol.356, 2012.

N. Rollins, M. Mahy, R. Becquet, L. Kuhn, T. Creek et al., Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models doi:10. 1136/sextrans-2012-050709 pmid:23172345. 14 WHO, UNICEF. Guideline updates on HIV and infant feeding Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group, Sex Transm Infect N Engl J Med, vol.356356, issue.2, pp.44-511173, 1056.

C. Kilewo, K. Karlsson, and A. Massawe, Mitra Study Team Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study, J Acquir Immune Defic Syndr, vol.356, pp.315-338, 2008.

N. Kumwenda, D. Hoover, and L. Mofenson, Extended Antiretroviral Prophylaxis to Reduce Breast-Milk HIV-1 Transmission, New England Journal of Medicine, vol.359, issue.2, pp.119-2910, 2008.
DOI : 10.1056/NEJMoa0801941

H. Coovadia, E. Brown, and M. Fowler, HPTN 046 protocol team Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial, Lancet, vol.356, issue.11, pp.221-229, 2012.

N. Nagot, C. Kankasa, and J. Tumwine, ANRS 12174 Trial Group Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial, Lancet, vol.356, issue.15, pp.566-73, 2016.

F. Foissac, J. Blume, and J. Tréluyer, ANRS 12174 Trial Group Are prophylactic and therapeutic target concentrations different? The case of lopinavir/ritonavir or lamivudine administered to infants for the prevention of mother-to-child HIV-1 transmission during breastfeeding, Antimicrob Agents Chemother, vol.356, pp.1869-1627895016, 2017.

R. Shapiro, S. Rossi, and A. Ogwu, Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study, Antivir Ther Lancet HIV, vol.356356, issue.16, pp.585-90, 2013.